Safety Of Dual Biological Therapy In A Patient Receiving Ocrelizumab For Multiple Sclerosis And Vedolizumab For Crohn'S Disease: A Case Report And Literature Review Update

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY(2021)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要